Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SDS3 homolog, SIN3A corepressor complex component pseudogene 1 (SUDS3P1) is a human processed pseudogene. It is a non-functional genomic element related by sequence homology to the functional SDS3 gene, which is a component of the SIN3A corepressor complex involved in chromatin remodeling and gene expression regulation. As a pseudogene, SUDS3P1 does not encode a functional protein product and is not considered an actionable therapeutic target. Like other pseudogenes, it may theoretically influence gene expression through RNA-based mechanisms (such as siRNA or miRNA decoy effects), but there is no current evidence that SUDS3P1 has a defined biological or clinical role. Key points: - SUDS3P1 is explicitly annotated as a pseudogene—it does not encode a functional protein or have direct therapeutic significance. - There is no evidence that SUDS3P1 acts as a receptor, enzyme, transporter, or bona fide molecular target. - No drugs, biomarkers, or safety considerations are associated with this pseudogene. - Its classification is “Other” (pseudogene), not any protein family or functional gene category. - SUDS3P1 should not be considered a canonical target for drug development or biological intervention. If you need details about the functional, protein-coding parental gene (such as SDS3/SUDS3), further context on chromatin remodeling, or the SIN3A corepressor complex, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SDS3 homolog, SIN3A corepressor complex component pseudogene 1 (SUDS3P1).